MAT1A and metabolic dysfunction-associated steatohepatitis: We confirmed the downregulation of GNMT and MAT1A expression in NASH [68, 77], key enzymes in the consumption and synthesis of SAM in the liver, respectively, and also found a marked reduction in ACHY expression, which codes for the enzyme in charge of metabolizing SAH into adenosine and homocysteine [80].